Skip to main content

Year: 2025

ALSTOM S.A: Alstom’s first half 2025/26: Excellent commercial momentum, sales ahead of plan, ready for a solid second half

Excellent commercial momentum, fuelled by Rolling Stock and North AmericaGroup book-to-bill ratio1 of 1.2 Rolling Stock book-to-bill ratio1 of 1.4All product lines contributing to strong sales growthGroup sales at €9,059 million, up 3.2%, of which 7.9% on an organic1 basis Strong sales performance in Europe (up 8.5%) supported by both Rolling Stock and SignallingSteady margin progressionAdjusted EBIT1 up 13% to €580 million compared to H1 2024/25 Adjusted EBIT margin1 of 6.4%, up 50bps compared to H1 2024/25Free-Cash-Flow seasonality as expectedContinuous progression in Funds From Operations1 (FFO) at €411 million Free-Cash-Flow1 (FCF) of €(740) million, reflecting expected working capital seasonalityNet profit (Group share) of €220 million, compared to €53 million for the first semester of fiscal year 2024/25 FY...

Continue reading

CAISSE FRANCAISE DE FINANCEMENT LOCAL EMTN 2024-6 D

Paris, 13 November 2025 Capitalised terms used herein shall have the meaning specified for such terms in the Caisse Française de Financement Local base prospectus to the €75,000,000,000 Euro Medium Term Note Programme dated 10 June 2025 (the “Base Prospectus”). Caisse Française de Financement Local has decided to issue on 17 November 2025 – Euro 150,000,000 Fixed Rate Obligations Foncières due 17 May 2039 to be assimilated upon listing and form a single series with the existing Euro 500,000,000 Fixed Rate Obligations Foncières due 17 May 2039 issued on 17 May 2024, the existing Euro 250,000,000 Fixed Rate Obligations Foncières due 17 May 2039 issued on 22 May 2024 and the existing Euro 150,000,000 Fixed Rate Obligations Foncières due 17 May 2039 issued on 13 November 2025. The Base Prospectus dated 10 June 2025 approved by the Autorité...

Continue reading

Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia

31,000-square-foot site expands Legend’s U.S. R&D footprint and strengthens its position as a global leader in cell therapy innovation The facility will support CAR-T R&D in potential oncology and immunology indicationsA Media Snippet accompanying this announcement is available by clicking on this link. SOMERSET, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) — Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a U.S.-based global leader in cell therapy, today announced the official opening and ribbon cutting of its new, state-of-the-art research and development (R&D) facility in Philadelphia, Pennsylvania. Located at 2300 Market Street, the 31,000-square-foot facility is now fully operational and will support Legend’s expanding pipeline of next-generation cell therapies. The site features cutting-edge laboratories...

Continue reading

Americas Gold and Silver Announces Upsize of “Bought Deal” Private Placement to US$115 Million

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICESOR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Americas Gold and Silver Corporation (TSX: USA) (NYSE American: USAS) (“Americas” or the “Company”) is pleased to announce that as a result of strong investor demand, the Company has amended its agreement with a syndicate of underwriters led by Canaccord Genuity Corp. and BMO Capital Markets (collectively, the “Underwriters”) to increase the size of its previously announced “bought deal” private placement to aggregate gross proceeds of US$115,000,000. The Offering (as defined herein) shall consist of 28,750,000 common shares of the Company (the “Common Shares”) at a price of US$4.00 per Common Share (the “Offering”). The Company has also granted the Underwriters an option to purchase up to an additional...

Continue reading

NEXTENSA ACHIEVES SOLID RESULTS IN Q3

REGULATED INFORMATIONBrussels, 13 November 2025, 5:55 PMRESULTS ON Q3 2025HIGHLIGHTS  NEXTENSA ACHIEVES SOLID RESULTS IN Q3 In the third quarter of 2025 Nextensa maintained its strong momentum and achieved a clear increase in profitability. Net profit increased significantly, driven by a higher contribution of development activities, lower financing costs and a further strengthening of the balance sheet. Three significant transactions were completed in Q3 2025:Sale of Retail Estates. On August 28,2025, Nextensa has sold its entire 8.99% stake in the Belgian REIT Retail Estates, generating proceeds of €89.6 M. Sale of Monteco in Belgium on September 17, 2025: 100% of the shares of Monteco BV were sold jointly with ION for a valuation of €28 M. Sale of retail property in Ingeldorf, Luxembourg, on September 29, 2025, to the State of...

Continue reading

Bonduelle – Combined General Meeting of December 4, 2025: Statement of availibilty of documents

BONDUELLE  Head office: “La Woestyne” – 59173 Renescure – FranceBonduelle a French S.C.A (Partnership limited by Shares) with a capital of 57 102 699,50 eurosRegistered under number : 447 250 044 ( Dunkerque Commercial and Companies Register) Villeneuve d’Ascq, November 13, 2025 Press release COMBINED GENERAL MEETING OF DECEMBER 4, 2025 Statement of availability of documents Shareholders are invited to attend the Combined General Meeting to be held on December 4, 2025 at 5 p.m. at the Company’s administrative headquarters, Rue Nicolas Appert, 59650 Villeneuve d’Ascq, France. The prior notice including the agenda and draft resolutions was published in the Bulletin des Annonces Légales Obligatoires (hereinafter “BALO”) no. 128 of October 24, 2025, and the notice of meeting will be published...

Continue reading

JCDecaux strengthens leadership in São Paulo Metro with the renewal and extension of contract for Lines 1-Blue, 2-Green, and 3-Red, and the inclusion of Line 15-Silver through 2036

         JCDecaux strengthens leadership in São Paulo Metro with the renewal and extension of contract for Lines 1-Blue, 2-Green, and 3-Red, and the inclusion of Line 15-Silver through 2036 Paris, November 13th, 2025 – JCDecaux SE (Euronext Paris: DEC), the number one outdoor advertising company worldwide, announces that its subsidiary JCDecaux Brazil has renewed and extended its advertising concession contract for the 1-Blue, 2-Green, and 3-Red lines of São Paulo Metro, along with the inclusion of Line 15-Silver, through 2036. The agreement, initially valid until 2030, has been extended to February 2036, adding six more years of operation and media management in São Paulo’s metro system. The contract renewal, as well as the expansion to Line 15-Silver, will take effect in February 2026. JCDecaux will be present in 63 metro stations...

Continue reading

Elis: Share capital increase reserved for employees “Elis for All 2025”

Share capital increase reserved for employees “Elis for All 2025” Saint-Cloud, 13 November 2025 The subscription period for the share capital increase reserved for Elis employees ended on 2 October 2025. 5.8% of employees in 20 countries chose to participate, either directly or via the Elis Group employee shareholding fund, in this operation, for a total subscription of nearly 15 million euros. Implemented by the Elis Supervisory Board on December 17, 2024 and by the Management Board on July 31, 2025, on the basis of a delegation of authority from the General Meeting of May 23, 2024 (France) and May 22, 2025 (foreign countries), the share capital increase allowed the Group’s employees to invest in Elis shares at a unit price of 16.86 euros, corresponding to the average opening price of the share from August 18 to September 12 2025,...

Continue reading

Ramsay Sante : Interim results at the end of September 2025

        PRESS RELEASE                Paris, 13th November 2025 Interim results at the end of September 2025 Revenue growth of 2.6% and Group EBITDA up 6.5% despite reduction in public funding; resilient operating performance Activity growth and cost control compensate constrained fundingUnaudited group revenue for the quarter ending 30 September 2025 increased by 2.6% to 1.21bn€ supported by activity volume growth, price indexation in Sweden and favourable foreign exchange movements. Revenue growth of 1.9% on a like-for-like basis. Acute hospitals admission volume growth in France and Sweden despite 1 less business day this quarter compared to the same period last year, reflecting sustained patient need for healthcare and the capacity of the group’s facilities to provide more quality care services in a competitive landscape. Unaudited...

Continue reading

Iceland Seafood International hf: Q1 2025 Uppgjör og fjárfestakynning

Áframhaldandi viðsnúningur, hagnaður fyrir skatta 590 milljónir ISK af reglulegri starfsemi Hagnaður fyrir skatta af reglulegri starfsemi nam 590 milljónum ISK (€4.1m) samanborið við 360 milljónir ISK (€2.5m) 9M 2024 sem er aukning um 230 milljónir ISK (€1.6m) Rekstrartekjur 9M 2025 námu 50,1 milljörðum ISK (€347.6m), sem er aukning um 11% eða 4,8 milljarða ISK (€33.6m) frá sama tímabili 2024 Framlegð fyrir 9M 2025 er 4,9 milljarðar ISK (€34.2m) samanborið við 4,1 milljarð ISK (€28.7m) á sama tímabili 2024 EBITDA fyrir 9M 2025 hækkaði um 55% í 2,0 milljarða ISK (€14.0m) frá 1,3 milljörðum ISK (€9.0m) 9M 2024 EBITDA síðustu 12 mánaða hækkaði um 0,9 milljarð ISK, í 3 milljarða ISK (€21.1m) frá 2,1 milljarði ISK (€14.8m) á Q3 2024 Hagnaður fyrstu níu mánuði eftir skatta er 360 milljónir ISK (€2.5m) samanborið við 216 milljóna ISK (€1.5m) tap fyrir...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.